MyMD Pharmaceuticals (MYMD) Competitor Comparison
We are evaluating the key criteria listed to compare MyMD Pharmaceuticals (MYMD) against its competitors in the Biotechnology industry.
Market Capitalization
352 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
0 / 337Free Cashflow
60 / 352Quick Ratio
308 / 357Earnings per Share
333 / 359Dividend yield
0 / 6Total Cash
327 / 358Performance 3 years
255 / 368Performance 5 years
309 / 368Performance 10 years
355 / 368Linearity 3 years
209 / 368Linearity 5 years
289 / 368Linearity 10 years
269 / 368Total Rank
205 / 368Dividend Rank
213 / 368Valuation Rank
312 / 368Piotroski Rank
297 / 368Muliplier Rank
9 / 368Dividend yield - MYMD ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.